+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Implantable Drug Delivery Devices Market - Segmented by Product Type, Technology, Application, Geography - Growth, Trends, and Forecasts (2018 - 2023)

  • ID: 4622318
  • Report
  • Region: Global
  • 114 pages
  • Mordor Intelligence
UP TO OFF
until Jul 01st 2019
1 of 5

FEATURED COMPANIES

  • 3M’s Health Care
  • Abbott
  • Allergan
  • Bausch and Lomb Inc.
  • Delpor Inc.
  • Medtronic
  • MORE
The implantable drug delivery devices market is expected to grow at a CAGR of 7.8%. The implantable drug delivery devices market is expected to witness a robust growth due to the recent developments taking place in genomics, proteomics and biotechnology that have led to emerging classes of novel pharmaceutical compounds across the globe that helps to accelerate the market. These implantable devices are gaining edge over conventional oral due to site specific and sustained release therapeutic action of implantable devices, which further minimizes the side-effects associated with the drug.

Increasing Prevalence of Chronic Diseases Boosts the Growth of Implantable Drug Delivery Devices Market
According to World Health Organization (WHO) 2017, chronic diseases are the major cause of disabilities worldwide. The estimated global burden by 2020 is 60% and moreover, 73% of deaths in 2020 is expected to be due to chronic diseases. The burden of chronic diseases is increasing rapidly. The proportion of the burden of the chronic diseases is expected to increase by 57% by 2020. Almost half of the total chronic disease deaths are attributable to cardiovascular diseases; obesity and diabetes and are found to affect a large proportion of the population. Thus the increase in burden of chronic disesaes is affecting the large patient population which increases the number of surgeries and hence drives the implantable drug delivery devices market.

The other driving factors also includes increasing demand for minimally invasive procedures and emergence of novel products.

High Cost of Devices to Restrain the Growth of Implantable Drug Delivery Devices Market
The substantial costs arise at the time of surgical implantation, as well as at the time of revision for expenditure of the devices for the catheter displacement, device malfunction or infection that requires surgical explantation or revision. Hence due to the substantial amount of high cost of devices and surgery costs, the adoption rate is less which is restraining the growth of implantable drug delivery devices market.

The other factors also includes stringent regulatory scenario.

North America Dominates the Implantable Drug Delivery Devices Market
North America is expected to dominate the implantable drug delivery devices market owing to new product launches in this region. Asia Pacific region is also anticipated to grow, attributed to the steadily growing healthcare spending as well as awareness levels of implantable drug delivery devices. The regulatory policies and healthcare infrastructure quality are further anticipated to broaden the scope for growth in this region.

Key Developments in the Implantable Drug Delivery Devices Market
Jan 2018: Medtronic Plc has received FDA approval of a new clinician programmer for use with the SynchroMed(TM) II Intrathecal Drug Delivery system, an implantable pump that provides targeted drug delivery for chronic pain and severe spasticity.
Oct 2016: Teleflex signs a new agreement with Premier for implantable infusion ports. The agreement begins November 1, 2016, and extends through October 31, 2019.

Implantable Drug Delivery Devices Market Major Players: Boston Scientific Corporation, Bausch and Lomb Inc., Delpor Inc., Medtronic, pSivida Corp. and Teleflex Incorporated among others.

Reasons to Purchase the Implantable Drug Delivery Devices Market Report
Current and future global implantable drug delivery devices market outlook in the developed and emerging markets
Analyzing various perspectives of the market with the help of Porter’s five forces analysis
The segment that is expected to dominate the market
Regions that are expected to witness fastest growth during the forecast period
Identify the latest developments, market shares and strategies employed by the major market players
3-month analyst support along with the Market Estimate sheet (in Excel)

Customization of the Implantable Drug Delivery Devices Market Report
This report can be customized to meet your requirements. Please connect with our representative who will ensure you get a report that suits your needs.

As part of this package, any purchases made up to 30th June will receive the following:

1) Free update of the report in 6 months on request 

2) Free Market Estimate sheet excel data sheet
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 3M’s Health Care
  • Abbott
  • Allergan
  • Bausch and Lomb Inc.
  • Delpor Inc.
  • Medtronic
  • MORE
1. Introduction
1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Implantable Drug Delivery Devices Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry

6. Implantable Drug Delivery Devices Market Dynamics
6.1 Drivers
6.1.1 Increasing Demand for Minimally Invasive Procedures
6.1.2 Emergence of Novel Products
6.1.3 Increasing Prevalence of Chronic Diseases
6.2 Restraints
6.2.1 High Cost of Devices
6.2.2 Stringent Regulatory Scenario
6.3 Opportunities
6.4 Key Challenges

7. Implantable Drug Delivery Devices Market Segmentation
7.1 By Product Type
7.1.1 Drug Infusion Pumps
7.1.2 Intraocular Drug Delivery Devices
7.1.3 Contraceptive Drug Delivery Devices
7.1.4 Stents
7.2 By Technology
7.2.1 Biodegradable Implants
7.2.2 Non-Biodegradable Implants
7.3 By Application
7.3.1 Oncology
7.3.2 Cardiovascular
7.3.3 Autoimmune Diseases
7.3.4 Obstetrics and Gynecology
7.3.5 Others
7.4 By Geography
7.4.1 North America Implantable Drug Delivery Devices Market (2018-2023)
7.4.1.1 United States Implantable Drug Delivery Devices Market (2018-2023)
7.4.1.2 Canada Implantable Drug Delivery Devices Market (2018-2023)
7.4.1.3 Mexico Implantable Drug Delivery Devices Market (2018-2023)
7.4.2 Europe Implantable Drug Delivery Devices Market (2018-2023)
7.4.2.1 France Implantable Drug Delivery Devices Market (2018-2023)
7.4.2.2 Germany Implantable Drug Delivery Devices Market (2018-2023)
7.4.2.3 United Kingdom Implantable Drug Delivery Devices Market (2018-2023)
7.4.2.4 Italy Implantable Drug Delivery Devices Market (2018-2023)
7.4.2.5 Spain Implantable Drug Delivery Devices Market (2018-2023)
7.4.2.6 Rest of Europe
7.4.3 Asia-Pacific Implantable Drug Delivery Devices Market (2018-2023)
7.4.3.1 China Implantable Drug Delivery Devices Market (2018-2023)
7.4.3.2 Japan Implantable Drug Delivery Devices Market (2018-2023)
7.4.3.3 India Implantable Drug Delivery Devices Market (2018-2023)
7.4.3.4 Australia Implantable Drug Delivery Devices Market (2018-2023)
7.4.3.5 South Korea Implantable Drug Delivery Devices Market (2018-2023)
7.4.3.6 Rest of Asia-Pacific
7.4.4 Middle East & Africa Implantable Drug Delivery Devices Market (2018-2023)
7.4.4.1 GCC Implantable Drug Delivery Devices Market (2018-2023)
7.4.4.2 South Africa Implantable Drug Delivery Devices Market (2018-2023)
7.4.4.3 Rest of the Middle East & Africa
7.4.5 South America Implantable Drug Delivery Devices Market (2018-2023)
7.4.5.1 Brazil Implantable Drug Delivery Devices Market (2018-2023)
7.4.5.2 Argentina Implantable Drug Delivery Devices Market (2018-2023)
7.4.5.3 Rest of South America

8. Company Profiles & Competitive Landscape
8.1 Abbott
8.2 Allergan
8.3 Boston Scientific Corporation
8.4 Bausch and Lomb Inc.
8.5 Delpor Inc.
8.6 Medtronic
8.7 Novartis (Alcon)
8.8 pSivida Corp.
8.9 Teleflex Incorporated
8.10 3M’s Health Care
* List Not Exhaustive

9. Future of the Implantable Drug Delivery Devices Market
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Abbott
  • Allergan
  • Boston Scientific Corporation
  • Bausch and Lomb Inc.
  • Delpor Inc.
  • Medtronic
  • Novartis (Alcon)
  • pSivida Corp.
  • Teleflex Incorporated
  • 3M’s Health Care
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4622318
Adroll
adroll